Log In
BCIQ
Print this Print this
 

LY2944876, TT-401, TT401

  Manage Alerts
Collapse Summary General Information
Company Transition Therapeutics Inc.
DescriptionPeptide dual agonist of glucagon-like peptide-1 (GLP-1) and glucagon receptor (GCGR)
Molecular Target Glucagon-like peptide-1 (GLP-1) ; Glucagon receptor (GCGR)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist; Glucagon receptor agonist
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today